Bipartisan insulin price cap introduced in House as lawmakers seek affordability win
AI Summary
A bipartisan group of House lawmakers, including some Republicans, has introduced new legislation to cap insulin prices at $35 per month for those with private health insurance. This long-discussed measure aims to address the skyrocketing costs that have burdened patients with diabetes. Despite previous resistance from some GOP members over government-set prices, the move signifies a significant step toward making insulin more affordable and highlights the growing bipartisan urgency to tackle healthcare costs.
Original Source
Read the full article at Thehill →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.